CellPly Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $8.33M

  • Investors
  • 16

CellPly General Information

Description

Developer of a diagnostic platform designed to support the development of novel cancer immunotherapies. The company's platform aims to provide diagnostic tools to define and monitor in vitro patient responses to drug treatments such as chemotherapy and monoclonal antibodies, enabling clinicians and researchers to analyze cell responses to drug treatments.

Contact Information

Website
www.cellply.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Giuseppe Massarenti, 61
  • 40138 Bologna
  • Italy
+39 051
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Via Giuseppe Massarenti, 61
  • 40138 Bologna
  • Italy
+39 051

CellPly Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellPly Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 23-Apr-2026 $8.33M Completed Generating Revenue
10. Accelerator/Incubator 06-Nov-2024 Completed Generating Revenue
9. Later Stage VC 07-Aug-2024 Completed Generating Revenue
8. Later Stage VC 27-Sep-2023 Completed Generating Revenue
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC 25-Jan-2022 Completed Generating Revenue
5. Accelerator/Incubator 07-Oct-2020 Completed Generating Revenue
4. Accelerator/Incubator 22-Nov-2018 Completed Generating Revenue
3. Grant 24-May-2018 $2.79M $2.61M Completed Generating Revenue
2. Grant 01-Dec-2016 $53.8K $2.61M Completed Generating Revenue
To view CellPly’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CellPly Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diagnostic platform designed to support the development of novel cancer immunotherapies. The company's pl
Discovery Tools (Healthcare)
Bologna, Italy
26 As of 2026

Beijing, China
 

Shirley, NY
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CellPly Competitors (2)

One of CellPly’s 2 competitors is ACROBiosystems, a Formerly VC-backed company based in Beijing, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ACROBiosystems Formerly VC-backed Beijing, China
Creative Bioarray Corporation Shirley, NY
You’re viewing 2 of 2 competitors. Get the full list »

CellPly Patents

CellPly Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026099711-A1 Method to define a dose-response Pending 05-Nov-2024
EP-4805723-A1 Method for testing in vitro activity on solid tumors of cells and/or actives Pending 08-Nov-2023
WO-2025099670-A1 Method for testing in vitro activity on solid tumors of cells and/or actives Inactive 08-Nov-2023
EP-4548096-A1 Method for the characterization of products for cell therapy Pending 28-Jun-2022
US-20250383338-A1 Method for the characterization of products for cell therapy Pending 28-Jun-2022 G01N33/5014
To view CellPly’s complete patent history, request access »

CellPly Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellPly Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tech and Biomedical Foundation Venture Capital Minority
EIC Scaling Club Accelerator/Incubator
CDP Venture Capital (Rome) Venture Capital Minority
LIFTT Venture Capital Minority
Rearden Accelerator/Incubator Minority
You’re viewing 5 of 16 investors. Get the full list »

CellPly FAQs

  • When was CellPly founded?

    CellPly was founded in 2013.

  • Where is CellPly headquartered?

    CellPly is headquartered in Bologna, Italy.

  • What is the size of CellPly?

    CellPly has 26 total employees.

  • What industry is CellPly in?

    CellPly’s primary industry is Discovery Tools (Healthcare).

  • Is CellPly a private or public company?

    CellPly is a Private company.

  • What is CellPly’s current revenue?

    The current revenue for CellPly is .

  • How much funding has CellPly raised over time?

    CellPly has raised $29.3M.

  • Who are CellPly’s investors?

    Tech and Biomedical Foundation, EIC Scaling Club, CDP Venture Capital (Rome), LIFTT, and Rearden are 5 of 16 investors who have invested in CellPly.

  • Who are CellPly’s competitors?

    ACROBiosystems and Creative Bioarray are competitors of CellPly.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process